Organoid Sciences Co., Ltd.

Organoid Sciences Co., Ltd. is a South Korean biotechnology company recognized for its pioneering work in organoid-based drug development. Founded in 2018 and headquartered in Seongnam, the company specializes in utilizing organoids—miniaturized and simplified versions of organs grown in vitro—to develop innovative treatments for diseases that are otherwise considered incurable. Organoid Sciences is particularly active in the realms of drug discovery, screening, and regenerative medicine, supporting both therapeutic development and advanced research applications. As part of this focus, the company develops regenerative therapies and provides cutting-edge solutions to accelerate the creation of new pharmaceuticals targeting complex and unmet medical needs. By leveraging organoid technology, Organoid Sciences is positioned at the intersection of biotechnology, medical research, and pharmaceutical innovation, contributing significantly to advancements in personalized medicine and disease modeling within the healthcare sector.